Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$20K Sell
1,500
-100
-6% -$1.51K ﹤0.01% 8016
2014
Q2
$32K Sell
1,600
-21,400
-93% -$317K ﹤0.01% 7458
2014
Q1
$438K Buy
23,000
+15,000
+188% +$285K ﹤0.01% 4376
2013
Q4
$136K Sell
8,000
-12,100
-60% -$185K ﹤0.01% 5718
2013
Q3
$314K Buy
20,100
+9,500
+90% +$121K ﹤0.01% 4647
2013
Q2
$127K Buy
+10,600
New +$108K ﹤0.01% 5603

Other funds holding INSM

UBS's INSM Position: Q3 2014 in Review

UBS increased its Insmed (INSM) stake by 195% in Q3 2014, buying an estimated $9.04M and bringing the position to 907,496 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1318.

UBS first reported a position in INSM in Q2 2013 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold INSM as of Q3 2014.

  • UBS held 907,496 shares of Insmed worth $11.8M as of Q3 2014.
  • UBS bought 599,564 Insmed shares in Q3 2014, an estimated $9.04M.
  • Insmed made up 0.01% of UBS's portfolio in Q3 2014, its #1318 holding.
  • UBS first reported a position in Insmed in Q2 2013 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Insmed as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.